Braxia Scientific Corp. (BRAXF)
OTC: BRAXF
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 06, 2025, 10:51 AM
Braxia Scientific Cash Flow Statement
Financials in CAD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | -9.64M | -10.9M | -12.98M | -13.14M | -12.29M | -12.65M | -12.01M | -12.13M | -7.54M | -6.56M | -6.78M | -88.45M | -89M | -87.61M | -85.68M |
Depreciation & Amortization | 365.45K | 481.51K | 590.6K | 565.88K | 410.26K | 225.99K | 48.29K | 23.17K | 21.98K | 19.43K | 20.61K | 19.8K | 17.57K | 17.48K | 11.57K |
Stock-Based Compensation | 128.1K | 274.14K | 656K | 859.11K | 1.12M | 1.91M | 2.34M | 2.42M | 2.12M | 1.18M | 393.95K | 3.1M | 3.03M | 3.03M | 3M |
Other Working Capital | 1.15M | -649.92K | -1.24M | -1.3M | -1.85M | -461.85K | 397.88K | 149.36K | 1.37M | 2.17M | 1.91M | 2.04M | 290.68K | -270.76K | -270.76K |
Other Non-Cash Items | 5.86M | 6.04M | 7.15M | 7.32M | 6.85M | 6.65M | 5.32M | 5.07M | 144.9K | 154.72K | 647.33K | 78.4M | 79.62M | 79.6M | 79.11M |
Deferred Income Tax | -419.31K | -948.4K | -1.55M | -1.7M | -1.6M | -2.02M | -2.1M | -2.13M | -2.17M | -1.22M | -871.58K | -564.06K | -487.48K | -487.48K | n/a |
Change in Working Capital | 1.15M | -649.92K | -1.24M | -1.3M | -1.85M | -461.85K | 397.88K | 149.36K | 1.37M | 2.17M | 2.24M | 2.37M | 624.39K | -27.14K | -356.5K |
Operating Cash Flow | -2.56M | -5.71M | -7.37M | -7.4M | -7.37M | -5.4M | -4.23M | -4.52M | -3.88M | -3.03M | -3.97M | -5.06M | -6.19M | -5.47M | -3.91M |
Capital Expenditures | -42.65K | 18.79K | -641.76K | -902.59K | -876.14K | -931.06K | -286.14K | -25.21K | -41.64K | -39.05K | -23.42K | -21.94K | n/a | n/a | n/a |
Cash Acquisitions | -13.51K | -13.51K | -11.73K | -11.73K | 1.79K | 1.79K | 1.48K | n/a | -21.94K | -21.94K | -23.42K | -1.31M | -1.28M | -1.28M | -1.28M |
Purchase of Investments | -11.12K | -11.12K | -11.12K | n/a | 233.24K | -21.37K | -21.37K | -38.35K | -273.99K | -19.38K | -19.38K | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 11.12K | 11.12K | 11.12K | 11.12K | n/a | n/a | n/a | 20.86K | 20.86K | 20.86K | 20.86K | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 27K | 126.98K | -8.99K | -125.28K | -684.23K | -1.04M | -931.34K | -800.05K | -225K | 29.61K | 28.54K | 21.94K | -7.67K | -7.67K | -5.12K |
Investing Cash Flow | -15.64K | 45.79K | -748.93K | -1.13M | -1.43M | -1.73M | -982.75K | -609K | -307.95K | -43.07K | -30K | -1.3M | -1.28M | -1.29M | -1.29M |
Debt Repayment | -73.52K | -37.28K | -35.69K | -27.8K | -20.95K | -16.01K | -13.7K | -11.39K | -23.89K | -22.56K | -18.58K | -14.6K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.26M | 1.26M | 1.26M | 1.26M | 2.64M | 2.64M | 2.64M | 2.72M | 60.82K | 117.64K | 115.08K | 14.41M | 14.42M | 14.37M | 14.37M |
Financial Cash Flow | 1.19M | 1.23M | 1.23M | 1.24M | 2.62M | 2.63M | 2.63M | 2.7M | 36.93K | 95.08K | 96.5K | 14.4M | 14.43M | 14.37M | 14.37M |
Net Cash Flow | -1.36M | -4.47M | -6.82M | -7.22M | -6.14M | -4.44M | -2.58M | -2.42M | -4.15M | -2.98M | -3.9M | 8.05M | 9.55M | 10.21M | 11.77M |
Free Cash Flow | -2.6M | -5.69M | -8.01M | -8.3M | -8.24M | -6.33M | -4.51M | -4.54M | -3.92M | -3.07M | -3.99M | -5.08M | -6.19M | -5.47M | -3.91M |